Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar® (sorafenib) and Stivarga® (regorafenib)
(Thomson Reuters ONE) -
CINCINNATI, March 2, 2015 - Advanced Care Scripts (ACS), a leading specialty
pharmacy and clinical services platform of Omnicare's Specialty Care Group, has
been chosen to dispense Bayer's Nexavar(®) (sorafenib) and Stivarga(®)
(regorafenib) as part of their limited distribution networks.
Nexavar is an anticancer medicine indicated for hepatocellular carcinoma (HCC),
advanced renal cell carcinoma (RCC), and differentiated thyroid carcinoma (DTC).
Stivarga is indicated for the treatment of patients with metastatic colorectal
cancer who have been previously treated with fluropyrimidine-, oxaliplatin-, and
irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild-type, an
anti-EGFR therapy. Stivarga also treats patients with locally advanced,
unresectable, or metastatic gastrointestinal stromal tumor who have been
previously treated with imatinib mesylate and sunitinib malate.
ACS has proven experience in successfully managing and dispensing specialty
medications, making it an ideal partner for pharmaceutical manufacturers. Its
expertise in providing access and reimbursement support enables an efficacious
process in navigating insurance benefits and financial assistance for patients.
ACS services are centrally coordinated to simplify reimbursement and delivery of
these complex treatments, and increase the speed to therapy for their patient
populations.
"We are extremely pleased to be part of the Bayer specialty pharmacy network,"
said Dennis Wilson, Vice President and General Manager of ACS. "As we continue
to leverage our differentiated expertise and service offering within this
growing therapeutic area, we are a compelling pharmacy solution for patients
being prescribed Nexavar and Stivarga. We look forward to providing
comprehensive pharmacy services for these important oncologic therapies."
About Omnicare Specialty Care Group
Omnicare Specialty Care Group (SCG) is a division of Omnicare, Inc., a Fortune
500 company and provider of comprehensive pharmaceutical services based in
Cincinnati, Ohio. Omnicare SCG is a combination of synergistic tenured companies
with a focused approach to pharmaceutical brand solutions. Together, Omnicare
SCG brings specialists in reimbursement methods, clinicians practiced in
medication therapy management for chronic disease states, and distribution
channel expertise. Solutions are tailored to drive product access by solving
challenges faced by patients and their caregivers, physicians, payers and
manufacturers. Custom programs are led by a single management team across the
organizational platforms, allowing coordination of resources and assets to
support positive outcomes for our patients. For more information, visit
www.omnicarescg.com.
About Advanced Care Scripts
Advanced Care Scripts, a specialty pharmacy, manages and dispenses specialty
medications and products nationwide. It coordinates services beginning with the
prescriber to simplify reimbursement and delivery of biotech therapies used to
treat cancer, infectious diseases, auto-immune disorders, multiple sclerosis,
hemophilia, and other disease states. Its customer service and comprehensive
patient care model provides compliance and adherence support and cost-effective
solutions for all classes of specialty medications.
# # #
Contact:
Patrick C. Lee
(513) 719-1507
patrick.lee(at)omnicare.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via GlobeNewswire
[HUG#1898287]
Unternehmensinformation / Kurzprofil:
Datum: 02.03.2015 - 13:45 Uhr
Sprache: Deutsch
News-ID 375368
Anzahl Zeichen: 4326
contact information:
Town:
Covington, KY
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 150 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Omnicare Specialty Care Group's ACS to Provide Specialty Pharmacy Services for Bayer's Nexavar® (sorafenib) and Stivarga® (regorafenib)"
steht unter der journalistisch-redaktionellen Verantwortung von
Omnicare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
